Literature DB >> 1538228

Efficacy of cyclophosphamide in sarcoid radiculomyelitis.

M Zuber, G Defer, P Cesaro, J D Degos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1538228      PMCID： PMC488987          DOI： 10.1136/jnnp.55.2.166-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  8 in total

1.  Spinal cord sarcoidosis.

Authors:  A L Day; G W Sypert
Journal:  Ann Neurol       Date:  1977-01       Impact factor: 10.422

2.  Sarcoid meningitis, high adenosine deaminase levels in CSF and results of cranial irradiation.

Authors:  C Garcia-Moncó; J Berciano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

3.  Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

Authors:  S L Hauser; D M Dawson; J R Lehrich; M F Beal; S V Kevy; R D Propper; J A Mills; H L Weiner
Journal:  N Engl J Med       Date:  1983-01-27       Impact factor: 91.245

Review 4.  Sarcoidosis and its neurological manifestations.

Authors:  B J Stern; A Krumholz; C Johns; P Scott; J Nissim
Journal:  Arch Neurol       Date:  1985-09

5.  Chlorambucil in sarcoidosis.

Authors:  Y P Kataria
Journal:  Chest       Date:  1980-07       Impact factor: 9.410

6.  [Isolated spinal cord involvement. Recurrence of sarcoidosis].

Authors:  D Leys; M Parent; H Petit
Journal:  Rev Neurol (Paris)       Date:  1986       Impact factor: 2.607

7.  Intramedullary sarcoidosis of the cervical spinal cord.

Authors:  A Vighetto; G Fischer; P Collet; B Bady; M Trillet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-05       Impact factor: 10.154

8.  Subacute myelopathy as the presenting manifestation of sarcoidosis.

Authors:  J Bogousslavsky; J P Hungerbühler; F Regli; H J Graf
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216
  8 in total
  7 in total

Review 1.  The use of immunosuppressive and cytotoxic drugs in non-malignant disease.

Authors:  P A Brogan; M J Dillon
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

2.  Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

3.  Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Med       Date:  2017-08       Impact factor: 10.057

Review 4.  Sarcoidosis of the spinal cord: literature review and report of eight cases.

Authors:  Samer Saleh; Chandan Saw; Kamel Marzouk; Om Sharma
Journal:  J Natl Med Assoc       Date:  2006-06       Impact factor: 1.798

Review 5.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

Review 6.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 7.  Endocrine aspects of neurosarcoidosis.

Authors:  G Murialdo; G Tamagno
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.